Gender differences in chronic respiratory disease, including cystic fibrosis and non-cystic
fibrosis bronchiectasis are clinically apparent and of increasing importance. Differences in …

Background Inhaled antibiotics have been incorporated into contemporary European and
British guidelines for bronchiectasis, yet no inhaled antibiotics have been approved in the …

Bronchiectasis is a condition that has been increasingly diagnosed by chest HRCT. In the
literature, bronchiectasis is divided into bronchiectasis secondary to cystic fibrosis and …

Objective Asthma is a frequent comorbidity of bronchiectasis, with possible implications for
exacerbation and severity. We investigated the clinical impact of asthma on bronchiectasis …

Bronchiectasis (BE) is a chronic and heterogeneous respiratory disease that requires a
multidimensional scoring system to properly assess severity. The aim of this study was to …

This is the first guideline developed by the Saudi Thoracic Society for the diagnosis and
management of noncystic fibrosis bronchiectasis. Local experts including pulmonologists …

Objectives Despite the clinical relevance of exacerbations in bronchiectasis (BE), little is
known about the microbiology and outcomes of pneumonic (CAP) vs. non-pneumonic …

Introduction The association between periodontal disease (PD) and chronic obstructive
pulmonary disease (COPD) has been widely studied, with aspiration of periodontal …

Background MUC1 is a membrane-tethered mucin expressed on the surface of epithelial
and hematopoietic cells. Previous studies have established that MUC1 attenuates airway …

Introduction Bronchiectasis is a very heterogeneous disease. This heterogeneity has several
consequences: severity cannot be measured by a single variable, so multidimensional …